Technology And Equipment Tenders

Open House Original Discount Contracts 2025-18 - Glycopyrronium Bromide/Formoterol (Combination of Active Ingredients)

Insulin Isophan (Human) (Dosage Form: Cylinder Ampoules)

Insulin, Normal (Human) (Dosage Form: Cylinder Ampoules)

Completion of Non-Exclusive Discount Agreements According to § 130 a (8) Sgb V with the Active Ingredient Minocycline

Completion of a Non-Exclusive Discount Contract According to Section 130A (8) Sgb V on Pharmaceuticals with the Active Ingredient Apremilast (Atc Code: L04aa32).

Completion of Non-Exclusive Discount Agreements According to § 130 a (8) Sgb V from 01.06.2025

Completion of a Non-Exclusive Discount Contract According to Section 130A (8) Sgb V for Medicinal Products with the Active Ingredient Denosumab (Atc Code: M05bx04).

Completion of a Non-Exclusive Discount Contract According to Section 130A (8) Sgb V for Pharmaceuticals with the Active Ingredient Combination of Clindamycin and Benzoylperoxide (Atc Code: D10af54).

Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Formoterol/Glycopyrronium/Budesonid (ATC-Code nach WHO: R03AL11)

Tafamidis (Effective Strength 61Mg)